WhyIs

Why is Abbott Laboratories stock down today?

September 2, 2026

Abbott Laboratories

ABT · NYQ · USD

$108.93
1.43 (1.30%)

vs. prev. close $110.36

Last updated Sep 1, 2026 20:03

Intraday Chart — 5-min intervals

📊
AI Summary

ABT · less than a minute ago

cached

Abbott Laboratories loses 1.30%: news, volume, and market context

Abbott Laboratories (ABT) is trading lower at $108.93, down 1.30% from the previous close of $110.36. The broader market is under pressure, with S&P 500: -0.7%, Nasdaq: -1.0%, Dow Jones: -0.8%, Shanghai: +0.7%, Hang Seng: -1.0%.

Two headlines stand out today: "Duncan Ferguson Joins Neovii Pharmaceuticals AG to Lead Global Commercial Expansion as Chief Commercial Officer" and "Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat". Taken together, the news tone looks mixed.

This is market context, not financial advice.

Key Factors

1NewMediaWire: Duncan Ferguson Joins Neovii Pharmaceuticals AG to Lead Global Commercial Expansion as Chief Commercial Officer
2MT Newswires: Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
3The Daily Upside: Abbott Introduces America’s First Liquid Baby Formula With Whole Milk
4Broad market: S&P 500: -0.7%, Nasdaq: -1.0%, Dow Jones: -0.8%, Shanghai: +0.7%, Hang Seng: -1.0%

Auto-generated analysis · Not financial advice

less than a minute ago
⚠️ Disclaimer: The information on this page is for informational purposes only and does not constitute financial advice. AI-generated summaries may be inaccurate. Always conduct your own research and consult a licensed financial advisor before making any investment decisions. Past performance is not indicative of future results.
🌐Market ContextRisk-Off 📉

S&P 500

-0.71%

Nasdaq

-1.03%

Dow Jones

-0.79%

Shanghai

+0.70%

Hang Seng

-1.00%

Nikkei 225

-2.33%

FTSE 100

-0.32%

Nifty 50

-0.50%

DAX

-2.26%

OMX Stockholm

-1.95%

Search another stock

🔍